Cardiovascular Diseases Clinical Trial
To field test the validity, reliability, cost, and cost-benefit of Health Risk Appraisal (HRA) instruments.
BACKGROUND:
Health Risk Appraisals instruments have provided the field of health promotion with an
imaginative motivational and instructional tool to foster personal behavioral change. A HRA
typically asked questions about smoking, blood pressure, exercise, medical history, diet and
other life style variables. These risk indicators were then compared to epidemiological and
mortality data to yield an estimate of an individual or group's risk for disease. They were
widely regarded as the most promising new addition to the health promotion armamentarium.
The National Health Information Clearinghouse divided them into the following three
categories: Computer-Scored HRAs, which were mailed to a central computer facility for batch
processing and were usually the more complex and detailed appraisals; Microcomputer-Based
HRAs, which c;ould be processed by a microcomputer at home, in schools or at the worksite;
and Self-Scored HRAs, which were usually brief, did not involve a computer, and were scored
by the user.
Although HRAs were a burgeoning industry in health education, no properly designed and
conducted scientific evaluation of them on a sufficiently large and representative sample of
the general population had been undertaken in the United States or elsewhere.
DESIGN NARRATIVE:
In the first stage, fourteen HRAs were evaluated by determining the validity of the scoring
system for estimating cardiovascular risk as employed in the Framingham Heart Study data
base, the accuracy of the reported risk factor scores as measured by physiological values,
and the understandability and social acceptability of the instrument format. The second
stage of the project was a field test to determine reliability and cost-effectiveness. Ten
groups of respondents were formed by randomly assigning eligible adults to one of the five
HRA groups and then to reliability and validity status.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|